Stem cell boost for poor graft function
Part of Blood & lymphatic clinical trials.
This study tests whether giving extra stem cells from your original donor can help your blood cell counts recover after a transplant. It is for people whose new immune system has not fully engrafted or whose counts are dangerously low.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have had a stem cell transplant from a donor (related, unrelated, or partially matched).
- Your new blood cells are not recovering as expected. This could be total failure to recover, low blood counts lasting 4+ weeks, or loss of function after initial recovery.
- Your original donor is still available and able to donate stem cells again.
- You are not pregnant (if you could become pregnant), and you have no known allergy to mouse proteins or iron dextran.
- Your blood counts are low and have not improved with standard growth factor treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether umbilical cord blood cells can help patients whose blood counts have dropped again after a stem cell transplant. It may be an option for people who have recovered initially but later develop low blood cell levels.
This study tests a modified second stem cell transplant for people whose first transplant failed. It uses half-matched (haploidentical) donor cells to try to restore healthy blood cells and treat the cancer.
This trial tests a second transplant using a half-matched donor for people whose first transplant failed. It may help if you have a blood cancer and are otherwise healthy enough for another procedure.
This trial tests whether a drug called decitabine can help improve poor graft function after a donor stem cell transplant. Poor graft function means your blood counts stay low because the donor stem cells are not working well enough. Decitabine may help stimulate the bone marrow to produce more blood cells.
This study tests whether giving special stem cells (called mesenchymal stem cells) can help improve poor graft function after a stem cell transplant. It aims to boost your blood cell counts so you recover better.
This trial offers a specialized device to help choose certain stem cells after a transplant when graft function is poor or not working. It may help improve how well the transplant takes and functions in your body.
Hear when a new Graft Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.